First-line therapy for type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study
In a young patient, even if the "reserve" is low, the "quality" of the remaining eggs is usually excellent
doi:10.1111/jcpt.13225 U.S
What #preoperative #anesthetic #GI concerns should one have when taking care of a patient on #GLP1 receptor agonists??
Lancet Diabetes Endocrinol 6:605617 Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH et al (2019) Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
49 MuM.AnP.WuQ.ShenX.ShaoD.WangH.et al (2016)